Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
On December 13, 2017, Amyris, Inc. (the “Company”) appointed Tina Maloney as its Chief Accounting Officer, reporting to the Company’s Chief Financial Officer.
Prior to joining the Company, Ms. Maloney, 55, served in various financial roles for The Cooper Companies Inc. from 2005 through 2017, most recently holding the position of Vice President, Corporate Controller and Principal Accounting Officer from January 2014 through January 2017. Ms. Maloney also previously served in several senior financial leadership roles at Sola International Inc. and IESL, Inc. Ms. Maloney holds a Master of Business Administration degree from William Woods University and a Bachelor of Science degree in Business Administration from Columbia College.
to an offer letter entered into between the Company and Ms. Maloney on December 13, 2017 (the “Offer Letter”), Ms. Maloney is expected to commence employment with the Company on January 2, 2018. The Offer Letter provides for an initial annual base salary for Ms. Maloney in the amount of $280,000. Ms. Maloney will also be eligible to receive an annual performance-based bonus, which is based on an initial bonus target of $112,000, subject to her achievement of performance objectives. In connection with Ms. Maloney’s appointment, the Company agreed to grant Ms. Maloney a stock option award and a restricted stock unit (“RSU”) award under the Company’s 2010 Equity Incentive Plan. The equity awards to Ms. Maloney consist of: (i) a non-statutory stock option to purchase 19,200 shares of the Company’s common stock (vesting over four years, with 25% of the shares subject to the option vesting upon completion by Ms. Maloney of her twelfth month of employment with the Company and the remainder vesting over the following three years in 36 equal monthly installments) at an exercise price equal to the fair market value of the Company’s common stock on the date of the grant; and (ii) an award of 12,800 RSUs, which would vest over three years in equal annual installments, in each case subject to continued service with the Company through the applicable vesting date. The Company also agreed to provide Ms. Maloney with a one-time signing bonus in the amount of $10,000, which amount would be repayable by Ms. Maloney in full in the event she voluntarily terminates her employment prior to the completion of one year of service with the Company.
Ms. Maloney will be eligible to participate in the Company’s compensation and benefits programs for employees on the same basis as other eligible employees, including health insurance; vacation, holidays and sick days; life insurance; disability insurance; and a Section 401(k) plan with an employer matching contribution.
About Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.
